Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-07-26

Clinical Trial Update: Valerian to Improve Sleep in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated valerian for improving sleep in patients with Parkinson's disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valerian (Valerian root extract)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Insomnia, Parkinson's Disease | Phase 2 | Status: COMPLETED